Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 3,4 5s 3?
Displaying drugs 11351 - 11375 of 12463 in total
Experimental
Matched Iupac: … (1E,3R)-3-hydroxyprop-1-ene-1,2,3-tricarboxylate …
An intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration. (From Martindale, The Extra Pharmacopoeia, 30th ed, p918)
Experimental
Matched Iupac: … propyl 2-{4-[(diethylcarbamoyl)methoxy]-3-methoxyphenyl}acetate …
Prifinium is an antimuscarinic agent with antispasmodic and antiemetic properties. It may be useful for the treatment of irritable bowel syndrome .
Experimental
Matched Iupac: … 3-(diphenylmethylidene)-1,1-diethyl-2-methylpyrrolidin-1-ium …
Experimental
Matched Iupac: … methyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate …
Experimental
Matched Iupac: … 3-[bis(thiophen-2-yl)methylidene]-1-methylpiperidine …
Experimental
Matched Iupac: … bismuth(3+) ion tetrabromobenzene-1,2-bis(olate) hydroxide …
Mesdopetam is under investigation in clinical trial NCT04435431 (A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia).
Investigational
Matched Iupac: … [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine …
GSK690693 has been used in trials studying the treatment of Tumor, CANCER, and Lymphoma.
Investigational
Matched Iupac: … -4-yl]-2-methylbut-3-yn-2-ol ... 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-piperidin-3-yl]methoxy}-1H-imidazo[4,5-c]pyridin …
Volrubigene ralaparvovec is under investigation in clinical trial NCT03223194 (Gene Transfer Clinical Study in Crigler-najjar Syndrome).
Investigational
Experimental
Matched Iupac: … 3-cyclohexyl-1-(4-iodophenyl)urea …
Experimental
Matched Iupac: … [3-(2-iodoacetamido)phenyl]boronic acid …
Experimental
Matched Iupac: … 1-ethylpiperidin-3-yl 2,2-diphenylacetate …
Experimental
Matched Iupac: … 5-(1,2-dithiolan-3-yl)pentanamide …
Experimental
Matched Iupac: … (3R)-3-(propanoyloxy)-4-(trimethylazaniumyl)butanoate …
Experimental
Matched Iupac: … (2R)-3-(hydroxysulfanyl)propane-1,2-diol …
Experimental
Matched Iupac: … 1-methyl-1H-imidazol-3-ium …
Experimental
Matched Iupac: … (E)-N''-(3-azaniumylpropyl)-N-hydroxyguanidine …
Experimental
Matched Iupac: … 3-hydroxy-3,5,5-trioxotrivanadoxan-1-oylolate …
Experimental
Matched Iupac: … aluminium(3+) 2-aminoacetate hydrate dihydroxide …
Experimental
Matched Iupac: … 2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane …
Methfuroxam is under investigation in clinical trial NCT01213407 (Dendritic Cell Cancer Vaccine for High-grade Glioma).
Investigational
Matched Iupac: … 2,4,5-trimethyl-N-phenylfuran-3-carboxamide …
Doramapimod is a P38 MAP kinase inhibitor.
Investigational
Matched Iupac: … 3-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-1-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea …
Anatibant is a selective, very potent, small-molecule Bradykinin B2 receptor antagonist. It is developed for the for the treatment of traumatic brain injury (TBI).
Investigational
Matched Iupac: … )pyrrolidin-2-yl]formamido}propyl)benzamide ... 4-carbamimidoyl-N-(3-{[(2S)-1-(2,4-dichloro-3-{[(2,4-dimethylquinolin-8-yl)oxy]methyl}benzenesulfonyl …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Investigational
Matched Iupac: … 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2,9-dimethyl-4H-pyrido[1,2-a]pyrimidin-4- …
Verubecestat is under investigation for the treatment of Alzheimer's Disease, Prodromal Alzheimer's disease, and Amnestic Mild Cognitive Impairment. Verubecestat is Merck’s investigational oral β-site amyloid precursor protein cleaving enzyme (BACE1 or β secretase) inhibitor. In July 2013, Merck announced positive results for Phase Ib trials of Verubecestat. In the study,...
Investigational
Matched Iupac: … }-5-fluoropyridine-2-carboxamide ... N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl]-4-fluorophenyl …
Displaying drugs 11351 - 11375 of 12463 in total